ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 105 filers reported holding ARATANA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,000 | -60.0% | 710 | -55.6% | 0.00% | – |
| Q4 2018 | $10,000 | -28.6% | 1,600 | -33.1% | 0.00% | – |
| Q3 2018 | $14,000 | +100.0% | 2,391 | +40.6% | 0.00% | – |
| Q2 2018 | $7,000 | +133.3% | 1,700 | +176.4% | 0.00% | – |
| Q1 2018 | $3,000 | -25.0% | 615 | -24.0% | 0.00% | – |
| Q4 2017 | $4,000 | -84.0% | 809 | -80.4% | 0.00% | – |
| Q3 2017 | $25,000 | +400.0% | 4,125 | +484.3% | 0.00% | – |
| Q2 2017 | $5,000 | -54.5% | 706 | -67.3% | 0.00% | – |
| Q1 2017 | $11,000 | +120.0% | 2,159 | +189.4% | 0.00% | – |
| Q4 2016 | $5,000 | – | 746 | +3008.3% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 24 | -99.4% | 0.00% | – |
| Q1 2016 | $22,000 | +100.0% | 4,000 | +97.7% | 0.00% | – |
| Q4 2015 | $11,000 | +22.2% | 2,023 | +81.1% | 0.00% | – |
| Q3 2015 | $9,000 | -50.0% | 1,117 | -7.9% | 0.00% | – |
| Q2 2015 | $18,000 | +260.0% | 1,213 | +304.3% | 0.00% | – |
| Q3 2013 | $5,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,184,942 | $31,784,000 | 4.70% |
| AWM Investment Company, Inc. | 1,562,517 | $9,578,000 | 1.67% |
| Opaleye Management Inc. | 420,000 | $2,574,000 | 0.91% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 0.75% |
| GENERAL AMERICAN INVESTORS CO INC | 867,600 | $5,318,000 | 0.50% |
| Grandeur Peak Global Advisors, LLC | 538,363 | $3,300,000 | 0.50% |
| Redmond Asset Management, LLC | 55,941 | $343,000 | 0.16% |
| WOODSTOCK CORP | 88,303 | $541,000 | 0.10% |
| CADENCE CAPITAL MANAGEMENT LLC | 173,808 | $1,065,000 | 0.07% |
| Sheaff Brock Investment Advisors, LLC | 71,000 | $435,000 | 0.06% |